Intermediate form of mucopolysaccharidosis type II (Hunter disease): a C1327 to T substitution in the iduronate sulfatase gene

Biochem Biophys Res Commun. 1992 Mar 16;183(2):809-13. doi: 10.1016/0006-291x(92)90555-y.

Abstract

Hunter disease, an X-linked recessive lysosomal storage disorder, is caused by a deficiency in iduronate sulfatase activity. Sequence analysis of mRNA of fibroblasts of an intermediate phenotype patient showed a single C1327 to T nucleotide transition. This mutation resulted in a substitution of termination codon for normal arginine at position 443 of the peptide sequence. Expression studies with this abnormal cDNA in fibroblasts from the patient revealed a loss of enzymatic activity and instability of the mutated protein. We posturate that this mutation is probably the cause of the intermediate form of Hunter disease.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Base Sequence
  • Child
  • Fibroblasts
  • Gene Expression
  • Humans
  • Iduronate Sulfatase / genetics*
  • Male
  • Molecular Sequence Data
  • Mucopolysaccharidosis II / genetics*
  • Mutation / genetics*
  • Pedigree
  • Phenotype
  • Transfection

Substances

  • Iduronate Sulfatase